1. Jornay PM is a new formulation of the ADHD drug methylphenidate, which patients take at night to reduce the severity of ADHD symptoms the next day.
2. Poteligeo injection is intended to treat two rare forms of Non-Hodgkin lymphoma: Mycosis fungoides and Sézary syndrome. The medication is the first drug approved to treat the latter condition.
3. Apotex‘s potassium chloride oral solution is used to treat low potassium levels in the blood and represents the first generic drug approved under the FDA’s Competitive Generic Therapy pathway.
More articles on supply chain:
Cervical cancer, strep B & adrenal gland tumors: 5 FDA approvals this week
Inova Health bans plastic straws: 5 things to know
Bayer fires back at scathing Netflix medical device documentary
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
